Levitee Labs adds to portfolio acquiring Calgary Addiction and Compounding Pharmacy

14 October, 2021

Levitee Labs adds to portfolio acquiring Calgary Addiction and Compounding Pharmacy

Levitee Labs (CSE:LVT) Chief Medical and Scientific Officer Fady Hannah-Shmouni joined Steve Darling from Proactive to share news the company has signed a Letter of Intent to acquire a compounding pharmacy in Calgary, Alberta.

Hannah-Shmouni tells Proactive this pharmacy will be used as an initial base for the production and distribution of pharmaceutical products for Levitee Labs. This will include expansion of operations and the current owner of the pharmacy will join Levitee Labs and assist with operations.

Via Proactive Investors

Learn more

Would you like to know more?

Contact us